{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:28:31Z","timestamp":1791181711561,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"INAGEMP \u2013 National Institute of Population Medical Genetics","award":["573993\/2008-4"],"award-info":[{"award-number":["573993\/2008-4"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.reprotox.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T13:30:56Z","timestamp":1428931856000},"page":"63-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil"],"prefix":"10.1016","volume":"53","author":[{"given":"Fernanda","family":"Sales Luiz Vianna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Zagonel","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa Vieira","family":"Sanseverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Faria","family":"Morelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dacio","family":"de Lyra Rabello Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Lopez-Camelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzi Alves","family":"Camey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Schuler-Faccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2015.03.007_bib0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tera.1420380303","article-title":"A short history of thalidomide embryopathy","volume":"38","author":"Lenz","year":"1988","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0165","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jmg.29.10.716","article-title":"Recognition of thalidomide defects","volume":"29","author":"Smithells","year":"1992","journal-title":"J Med Genet"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of LEPRA reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.47276\/lr.80.4.355","article-title":"Interventions for erythema nodosum leprosum. A Cochrane review","volume":"80","author":"Van Veen","year":"2009","journal-title":"Lepr Rev"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0180","doi-asserted-by":"crossref","first-page":"e1711","DOI":"10.1371\/journal.pntd.0001711","article-title":"Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study","volume":"6","author":"Duppre","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0185","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0190","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0195","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","article-title":"Thalidomide: a review of approved and investigational uses","volume":"25","author":"Matthews","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0102-311X1999000100011","article-title":"Talidomida no Brasil: vigil\u00e2ncia com responsabilidade compartilhada?","volume":"15","author":"Oliveira","year":"1999","journal-title":"Cadernos de Saude Publica"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0210","first-page":"449","article-title":"A trag\u00e9dia da Talidomida e o Advento da Teratologia Experimental","volume":"17","author":"Saldanha","year":"1994","journal-title":"Rev Bras Genet"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0215","first-page":"373","article-title":"Leprosy in Brazil","volume":"36","author":"Araujo","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0220","series-title":"Di\u00e1rio Oficial da Uni\u00e3o","author":"ANVISA ANdVS (2003) Law 10651\/03","year":"2003"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0225","series-title":"Resolu\u00e7\u00e3o RDC N\u00b0 11 de 22 de mar\u00e7o de 2011","author":"Di\u00e1rio-Oficial-da-Uni\u00e3o-D.O.U (22 de mar\u00e7o de 2011.)","year":"2011"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0230","series-title":"Situa\u00e7\u00e3o Epidemiol\u00f3gica Hansen\u00edase Brasil \u2013 2011","author":"Minist\u00e9rio da Sa\u00fade","year":"2012"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#","article-title":"Thalidomide, a current teratogen in South America","volume":"54","author":"Castilla","year":"1996","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/bdra.20384","article-title":"New cases of thalidomide embryopathy in Brazil","volume":"79","author":"Schuler-Faccini","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"7","key":"10.1016\/j.reprotox.2015.03.007_bib0245","doi-asserted-by":"crossref","first-page":"e21735","DOI":"10.1371\/journal.pone.0021735","article-title":"Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil","volume":"6","author":"Vianna","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0250","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1590\/S1413-81232007000300014","article-title":"Quality analysis of Brazilian vital statistics: the experience of implementing","volume":"12","author":"Jorge","year":"2007","journal-title":"Cien Saude Colet"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MCD.0b013e32835ffc58","article-title":"Recognition of the phenotype of thalidomide embryopathy in countries endemic for leprosy: new cases and review of the main dysmorphological findings","volume":"22","author":"Vianna","year":"2013","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0260","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y","article-title":"Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses","volume":"60","author":"Miller","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0265","first-page":"105","article-title":"Clinical studies on teenage Brazilian victims of thalidomide","volume":"16","author":"Schmidt","year":"1983","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0270","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/ajmg.a.33999","article-title":"Anatomic and etiological classification of congenital limb deficiencies","volume":"155A","author":"Gold","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0275","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0095-5108(18)30810-8","article-title":"The thalidomide syndrome: risks of exposure and spectrum of malformations","volume":"13","author":"Newman","year":"1986","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0280","first-page":"135","article-title":"Sistema de informa\u00e7\u00e3o de agravos de notifica\u00e7\u00e3o em sa\u00fade (Sinan): desafios no desenvolvimento de um sistema de informa\u00e7\u00e3o em sa\u00fade","volume":"13","author":"Laguardia","year":"2004","journal-title":"Epidemiol Serv Sa\u00fade"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/oxfordjournals.epirev.a017993","article-title":"Spatial analytical methods and geographic information systems: use in health research and epidemiology","volume":"21","author":"Moore","year":"1999","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0290","series-title":"Resolution of the research involving human subjects in Brazil (466\/2012) Resolu\u00e7\u00e3o 466\/2012","author":"National Health Council","year":"2012"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0300","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1590\/S0102-311X2009000800008","article-title":"Quality of reporting on birth defects in birth certificates: case study from a Brazilian reference hospital","volume":"25","author":"Luquetti","year":"2009","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0305","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1590\/S0102-311X2010000900009","article-title":"Quality of birth defect reporting in the Brazilian Information System on Live","volume":"26","author":"Luquetti","year":"2010","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.reprotox.2015.03.007_bib0310","first-page":"112","article-title":"Validity and reliability of the Brazilian birth certificate for reporting birth","volume":"37","author":"Luquetti","year":"2010","journal-title":"J Regist Manage"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623815000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623815000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:58Z","timestamp":1760189938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623815000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"alternative-id":["S0890623815000416"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2015.03.007","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}